Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ira M Longini

Showing results (81-90 of 171) with videos related to

Pageof 18
Sort By:
Clinical Trials (London, England)|February 4, 2021
COVID-19 vaccine trials: The use of active controls and non-inferiority studiesThomas R Fleming, Philip R Krause, Martha Nason, et al.
Lancet (London, England)|March 23, 2018
Questionable efficacy of the rVSV-ZEBOV Ebola vaccine - Authors' replyIra M Longini, John-Arne Røttingen, Marie Paule Kieny, et al.
BMC Medical Research Methodology|January 23, 2025
Analysis methods for covariate-constrained cluster randomized trials with time-to-event outcomesAmy M Crisp, M Elizabeth Halloran, Matt D T Hitchings, et al.
Epidemiology (Cambridge, Mass.)|May 31, 2018
Transmissibility of Norovirus in Urban Versus Rural Households in a Large Community Outbreak in ChinaTim K Tsang, Tian-Mu Chen, Ira M Longini, et al.
Vaccine|January 18, 2005
Population-wide benefits of routine vaccination of children against influenzaDerek Weycker, John Edelsberg, M Elizabeth Halloran, et al.
Medrxiv : the Preprint Server for Health Sciences|November 23, 2022
Estimating the impact of COVID-19 vaccine allocation inequities: a modeling studyNicolò Gozzi, Matteo Chinazzi, Natalie E Dean, et al.
Sexually Transmitted Diseases|March 31, 2010
Population level impact of an imperfect prophylactic vaccine for herpes simplex virus-2Ramzi A Alsallaq, Joshua T Schiffer, Ira M Longini, et al.
Nature Communications|June 5, 2023
Estimating the impact of COVID-19 vaccine inequities: a modeling studyNicolò Gozzi, Matteo Chinazzi, Natalie E Dean, et al.
Lancet (London, England)|April 27, 2016
Changes in the primary outcome in Ebola vaccine trial--Authors' replyMarie Paule Kieny, Ira M Longini, Ana Maria Henao-Restrepo, et al.
Lancet (London, England)|September 24, 2022
Evolutionary consequences of delaying intervention for monkeypoxPhilip L F Johnson, Carl T Bergstrom, Roland R Regoes, et al.
Pageof 18

Showing results (81-90 of 171) with videos related to

Sort By:
Pageof 18
Clinical Trials (London, England)|February 4, 2021
COVID-19 vaccine trials: The use of active controls and non-inferiority studiesThomas R Fleming, Philip R Krause, Martha Nason, et al.
Lancet (London, England)|March 23, 2018
Questionable efficacy of the rVSV-ZEBOV Ebola vaccine - Authors' replyIra M Longini, John-Arne Røttingen, Marie Paule Kieny, et al.
BMC Medical Research Methodology|January 23, 2025
Analysis methods for covariate-constrained cluster randomized trials with time-to-event outcomesAmy M Crisp, M Elizabeth Halloran, Matt D T Hitchings, et al.
Epidemiology (Cambridge, Mass.)|May 31, 2018
Transmissibility of Norovirus in Urban Versus Rural Households in a Large Community Outbreak in ChinaTim K Tsang, Tian-Mu Chen, Ira M Longini, et al.
Vaccine|January 18, 2005
Population-wide benefits of routine vaccination of children against influenzaDerek Weycker, John Edelsberg, M Elizabeth Halloran, et al.
Medrxiv : the Preprint Server for Health Sciences|November 23, 2022
Estimating the impact of COVID-19 vaccine allocation inequities: a modeling studyNicolò Gozzi, Matteo Chinazzi, Natalie E Dean, et al.
Sexually Transmitted Diseases|March 31, 2010
Population level impact of an imperfect prophylactic vaccine for herpes simplex virus-2Ramzi A Alsallaq, Joshua T Schiffer, Ira M Longini, et al.
Nature Communications|June 5, 2023
Estimating the impact of COVID-19 vaccine inequities: a modeling studyNicolò Gozzi, Matteo Chinazzi, Natalie E Dean, et al.
Lancet (London, England)|April 27, 2016
Changes in the primary outcome in Ebola vaccine trial--Authors' replyMarie Paule Kieny, Ira M Longini, Ana Maria Henao-Restrepo, et al.
Lancet (London, England)|September 24, 2022
Evolutionary consequences of delaying intervention for monkeypoxPhilip L F Johnson, Carl T Bergstrom, Roland R Regoes, et al.
Pageof 18